[EN] 2-AZABICYCLO[3.1.1] DERIVATIVES AS ANTAGONISTS OF THE OREXIN-1 AND OREXIN-2 RECEPTORS<br/>[FR] DÉRIVÉS DE 2-AZABICYCLO[3.1.1] UTILISÉS EN TANT QU'ANTAGONISTES DES RÉCEPTEURS DE L'OREXINE-1 ET DE L'OREXINE-2
申请人:CHRONOS THERAPEUTICS LTD
公开号:WO2019081939A1
公开(公告)日:2019-05-02
There is provided a compound of formula I, wherein L1, R1, R2, R5, X, A and B have meanings given in the description, and pharmaceutically acceptable salts, solvates and prodrugs thereof, which compounds are useful as antagonists of the orexin-1 and orexin-2 receptors or as selective antagonists of the orexin-1 receptor, and thus, in particular, in the treatment or prevention of inter alia substance dependence, addiction, anxiety disorders, panic disorders, binge eating, compulsive disorders, impulse control disorders, cognitive impairment and Alzheimer's disease.
提供了一种具有I式结构的化合物,其中L1、R1、R2、R5、X、A和B的含义如描述中所给,并且其药学上可接受的盐、溶剂合物和前药,这些化合物可用作促进促进素-1和促进素-2受体的拮抗剂或促进素-1受体的选择性拮抗剂,因此,特别适用于治疗或预防物质依赖、成瘾、焦虑障碍、恐慌障碍、暴饮暴食、强迫障碍、冲动控制障碍、认知障碍和阿尔茨海默病等疾病。